• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION THORATEC® HEARTMATE II®, LVAS IMPLANT KIT, US, EP; Ventricular (assist) bypass

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION THORATEC® HEARTMATE II®, LVAS IMPLANT KIT, US, EP; Ventricular (assist) bypass Back to Search Results
Model Number 103695
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Bacterial Infection (1735); Hemolysis (1886); Skin Infection (4544); Lactate Dehydrogenase Increased (4567)
Date of Event 08/03/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturer's investigation conclusion: a specific cause of the patient's driveline infection could not be determined.Additionally, a direct correlation between heartmate (hm) ii left ventricular assist system (lvas), serial number (b)(6), and the reported events could not be conclusively established through this evaluation.The submitted log files collectively contained events and data from (b)(6) 2025.No notable alarms or events, or significant fluctuations in pump parameters were captured.The pump appeared to function as intended and operated at or above the lsl for the duration of the file.The patient remains ongoing on hmii lvas, serial number (b)(6).No further related events have been reported at this time.The heartmate ii left ventricular assist system (lvas) instructions for use (ifu), rev.B and the heartmate ii patient handbook, rev.A, are currently available.Section 1 of the ifu, ¿introduction¿, lists potential adverse events, including hemolysis, hepatic dysfunction, and infection (local, driveline, pump pocket or pseudo pocket), that may be associated with the use of the heartmate ii left ventricular assist system.Section 6 of the ifu, "patient care and management", also lists infection as a potential late postimplant complication.Section 6, under "anticoagulation", contains information regarding the recommended anticoagulation therapy and international normalized ratio (inr) range, as well as suggested anticoagulation modifications.Furthermore, several sections of the heartmate ii ifu and patient handbook provide care instructions regarding how to prevent infection as well as the suggested responses in the event an infection occurs.The current revision of the ifu and patient handbook can be found on the eifu page of the abbott website.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Event or Problem Description
It was reported that the patient was admitted with rising lactate dehydrogenase (ldh) of 1,200.No alarms were noted.Log files captured routine events throughout the log.At this time, there were no plans for computed tomography angiography (cta) or echocardiogram (echo) as the patient was clinically stable and had a history of fluctuating ldh levels.The cause of elevated ldh was determined to be multifactorial, chronic macroangiopathic hemolysis due to the left ventricular assist device (lvad), hepatic congestion from heart failure exacerbation, and ongoing chronic infection.Delafloxacin was given for chronic infection.Ldh continued to trend.The patient was not having any other symptoms at this time.Additional log files showed no unusual events recorded.There were no changes to the infection including source, culture, or symptoms/treatment since (b)(6) 2017, which was the date of onset infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THORATEC® HEARTMATE II®, LVAS IMPLANT KIT, US, EP
Common Device Name
Ventricular (assist) bypass
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
lindsey sallese
6035 stoneridge drive
pleasanton, CA 94588
7818528207
MDR Report Key22906879
Report Number2916596-2025-05411
Device Sequence Number12762695
Product Code DSQ
UDI-Device Identifier00813024010616
UDI-Public(01)00813024010616(17)121231
Combination Product (Y/N)N
Initial Reporter StateDC
Initial Reporter CountryUS
PMA/510(K) Number
P060040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 08/27/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date12/31/2013
Device Model Number103695
Device Catalogue Number103695
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/08/2025
Initial Report FDA Received Date08/27/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/01/2011
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age72 YR
Patient SexMale
Patient Weight133 KG
-
-